NEW YORK (GenomeWeb News) - Bioanalytical contract services provider Advion BioSciences this week said it has acquired microfluidic chemistry firm NanoTek for an undisclosed sum.
 
Advion said it plans to use NanoTek's technology in combination with its own micro- and nanoscale LC-MS analytical platform to offer chemistry and analytical services for biomarker research, drug discovery, and imaging diagnostics.
 
Prior to the acquisition, Advion was NanoTek’s global distribution and support partner.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.